По вашему запросу найдено документов: 578
Страница 7 из 58
Dabigatran etexilate in patients with nonvalvular atrial fibrillation: Benefits of application in certain clinical situations atrial fibrillation (AF). The efficacy and safety profile of dabigatran etexilate and a group of patients
The modern approach to stroke preventionin patients with atrial fibrillation: ROCKET AFand J-ROCKET AF studies-valvular atrial fibrillation and the results of ROCKET AF and J-ROCKET AF studies that con- firmed the efficacy
SELECTION OF ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING CARDIOVERSIONCriteria of selection of anticoagulants in patients with atrial fibrillation undergoing
Multiphase patient-specific simulations to study fibrillation-induced thrombosis in the left atrial appendageThrombosis commonly develops in the left atrial appendage of patients with atrial fibrillation
New direct oral anticoagulants for treatment of patients with atrial fibrillation in real-world settingLarge randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF
Antiplatelet therapy of atrial fibrillation: Focus on the elderlyCurrent guidelines for the management of atrial fibrillation (AF) recommend using anticoagulants
Approaches to antithrombotic therapy in elderly patients with atrial fibrillationAdvanced age is the most important and independent risk factor for the development of atrial
Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)-dose oral anticoagulation has entered the CAD arena. Atrial fibrillation (AF) is often seen in CAD and vice
Cognitive dysfunction at the background of atrial fibrillation: Clinical-pathological aspects, diagnostics and prevention, issues of the use of the application of anticoagulant therapy [Когнитивная дисфункция на фоне фибрилляции предсердий: клинико-патогенетические аспекты, диагностика и профилактика, вопросы применения антикоагулянтной терапии]Atrial fibrillation (AF) and cognitive dysfunction - common states with similar risk factors
Enalapril in coronary heart disease and atrial fibrillation in secondary prevention of myocardial infarction, as well as primary and secondary prevention of atrial
Страница 7 из 58
Фасеты
Партнеры
Индексация
